This is a past event. Registration is closed. View other NewYorkBIO events.


To livestream the event, CLICK HERE.


Hosted by NewYorkBIO, this annual event brings together patients, advocacy groups, and life science and biotechnology leaders for a morning of engaging content, new perspectives, and important conversations.

Tickets

Agenda

9

00AM

-

9

05AM

Welcome Remarks

Jennifer Hawks Bland

A welcome from NewYorkBIO's CEO, Jennifer Hawks Bland.

9

05AM

-

9

10AM

9

10AM

-

9

15AM

9

15AM

-

10

00AM

Panel: Decentralizing Clinical Trials

Yihenew AbetuJordyne BlaiseErica Courtenay-MannAlicia Staley

Clinical trials have largely been run out of academic medical centers, which provide a location for most patient visits, consultations, and interventions. The COVID-19 pandemic challenged the status quo of large site-based clinical trials, providing an opportunity for the use of telemedicine, remote monitoring, and reporting to allow trials to “meet patients where they are”. What can be expected from decentralized trials in the future? What are some of the best practices to emerge and how will the industry adopt, adapt, and innovate regarding how to recruit and communicate with patients during clinical development?

10

00AM

-

10

05AM

10

05AM

-

10

50AM

Panel: The Future of Patient Centricity

Eric GaschoSarah KrügLuke RosenGrant Cale

Patients are the core of the bioscience industry – success is measured in improved patient outcomes. Bioscience companies spend decades to research and develop new therapies, diligently pursue new technologies and platforms that have the potential to improve human health, but historically patients were on the sidelines of this process. This has, thankfully, started to change, with bioscience companies becoming more “patient centric” and inclusive, taking feedback from patients and caregivers, and making decisions based on patients’ needs and perspectives. Now that patients have a proverbial seat at the table, what’s next? This panel will discuss best practices, as well as still-untapped opportunities for patient voices.

10

50AM

-

10

55AM

10

55AM

-

11

10AM

11

10AM

-

11

15AM

11

15AM

-

12

00PM

Panel: Patients and Policy: Moving the Needle

Maya BerminghamDr. Gary PuckreinJen RomanChristopher Cox

Policymakers consider several different angles when crafting legislation that often has a broad impact on patients, our healthcare system, and the companies in the life science industry. While there are several factors that contribute to the value of a particular therapy or intervention, a patient’s lived experience can make a lasting impact on an elected official or policy maker. The panel will discuss potential ways to impact change and move the needle on key policy issues facing the bioscience industry over the coming decade.

12

00PM

-

12

05PM

12

05PM

-

12

50PM

Panel: The Importance of Biomarkers

Michael DavoliDr. Wojciech SwatTiffany Westrich-RobertsonDr. Carl Morrison

As our industry pushes farther along the spectrum of precision medicine – with the goal of delivering the right drug to the right patient at the right time - biomarkers will play an increasingly important role in driving better outcomes for patients. This panel will look at how biomarkers are impacting the future of clinical and commercial development for new therapeutics and how they are changing the landscape of how to think about new therapies.

12

50PM

-

12

55PM

12

55PM

-

1

00PM

Closing Remarks

Jennifer Hawks Bland

Final thoughts from NewYorkBIO's CEO, Jennifer Hawks Bland.

Speakers

  • Yihenew Abetu (Clinical Trials Director of SUNY Downstate Medical Center)

    Yihenew Abetu

    Clinical Trials Director of SUNY Downstate Medical Center

    More Information

  • Maya Bermingham (Senior Vice President, Public Policy and Government Affairs at Regeneron Pharmaceuticals, Inc.)

    Maya Bermingham

    Senior Vice President, Public Policy and Government Affairs at Regeneron Pharmaceuticals, Inc.

    More Information

  • Jordyne Blaise (Vice President for Equity and Community Engagement at Circuit Clinical)

    Jordyne Blaise

    Vice President for Equity and Community Engagement at Circuit Clinical

    More Information

  • Grant Cale (Senior Director of Alliance Development at Bristol Myers Squibb Company)

    Grant Cale

    Senior Director of Alliance Development at Bristol Myers Squibb Company

    More Information

  • Erica Courtenay-Mann (Foundation for Sarcoidosis Research)

    Erica Courtenay-Mann

    Foundation for Sarcoidosis Research

    More Information

  • Christopher Cox (Chief of Staff at Congresswoman Yvette D. Clarke)

    Christopher Cox

    Chief of Staff at Congresswoman Yvette D. Clarke

    More Information

  • Sneha Dave (Executive Director of Generation Patient)

    Sneha Dave

    Executive Director of Generation Patient

    More Information

  • Michael Davoli (Senior Government Relations Director, New York of ACS-CAN)

    Michael Davoli

    Senior Government Relations Director, New York of ACS-CAN

    More Information

  • Eric Gascho (Senior Vice President, Policy and Government Affairs at National Health Council)

    Eric Gascho

    Senior Vice President, Policy and Government Affairs at National Health Council

    More Information

  • Jennifer Hawks Bland (Chief Executive Officer at NewYorkBIO)

    Jennifer Hawks Bland

    Chief Executive Officer at NewYorkBIO

    More Information

  • Sarah Krüg (Executive Director of CANCER101)

    Sarah Krüg

    Executive Director of CANCER101

    More Information

  • Indie Lee (Founder & CEO of Indie Lee)

    Indie Lee

    Founder & CEO of Indie Lee

    More Information

  • Tracey Meeks (Senior Director, Patient Advocacy of Vertex Pharmaceuticals Inc.)

    Tracey Meeks

    Senior Director, Patient Advocacy of Vertex Pharmaceuticals Inc.

    More Information

  • Dr. Carl Morrison (Senior Vice President, Scientific Development and Integrative Medicine at Roswell Park Cancer Institute)

    Dr. Carl Morrison

    Senior Vice President, Scientific Development and Integrative Medicine at Roswell Park Cancer Institute

    More Information

  • Joanna Pascal (Patient Advocate at Children’s Cardiomyopathy Foundation)

    Joanna Pascal

    Patient Advocate at Children’s Cardiomyopathy Foundation

    More Information

  • Dr. Gary Puckrein (Chief Executive Officer at National Minority Quality Forum)

    Dr. Gary Puckrein

    Chief Executive Officer at National Minority Quality Forum

    More Information

  • Luke Rosen (Founder & Board Chair of KIF1A.ORG)

    Luke Rosen

    Founder & Board Chair of KIF1A.ORG

    More Information

  • Hillary Savoie (Founder of The Cute Syndrome Foundation)

    Hillary Savoie

    Founder of The Cute Syndrome Foundation

    More Information

  • Alicia Staley (Vice President, Patient Engagement at Medidata Solutions)

    Alicia Staley

    Vice President, Patient Engagement at Medidata Solutions

    More Information

  • Dr. Wojciech Swat (Interim Director of Cancer Genomics at Bioreference)

    Dr. Wojciech Swat

    Interim Director of Cancer Genomics at Bioreference

    More Information

  • Tiffany Westrich-Robertson (CEO of International Foundation for Autoimmune & Autoinflammatory Arthritis)

    Tiffany Westrich-Robertson

    CEO of International Foundation for Autoimmune & Autoinflammatory Arthritis

    More Information

  • Kerry Wong (Creator at Float Like a Buttahfly)

    Kerry Wong

    Creator at Float Like a Buttahfly

    More Information

  • Brianna Worden

    Brianna Worden

    More Information

Sponsors and Partners

Organizer

Presenting Company

Leadership Level

Panel Sponsor

Silver Sponsor

Bronze Sponsor

Partner Organizations

Community

Connect with 241 people attending this event